COBISS Co-operative Online Bibliographic system & services COBISS
Nadica Sibinovska
Personal bibliography for the period 2019-2022
2019
1.
SIBINOVSKA, Nadica, ŽAKELJ, Simon, KRISTAN, Katja. Suitability of RPMI 2650 cell models
for nasal drug permeability prediction. European journal of pharmaceutics and biopharmaceutics. [Print ed.]. 2019, vol. 145, str. 85-95, ilustr. ISSN 0939-6411. https://www.sciencedirect.com/science/article/pii/S0939641119308732, DOI: 10.1016/j.ejpb.2019.10.008. [COBISS.SI-ID 1518174]
2020
2.
BERGINC, Katja, SIBINOVSKA, Nadica, ŽAKELJ, Simon, TRONTELJ, Jurij, LEGEN, Igor. Biopharmaceutical
classification of desloratadine - not all drugs are classified the easy way. Acta pharmaceutica. 2020, vol. 70, iss. 2, str. 131-144, ilustr. ISSN 1330-0075. https://sciendo.com/article/10.2478/acph-2020-0006, Repository of the University of Ljubljana – RUL , DOI: 10.2478/acph-2020-0006. [COBISS.SI-ID 4797553]
project: P1-0189; funder: ARRS
project: P1-0189; funder: ARRS
3.
SIBINOVSKA, Nadica, ŽAKELJ, Simon, KRISTAN, Katja. In vitro cell models for nasal
drug permeability determination. In: Third ALL WGs UNGAP Meeting, 11th - 12th February 2020 : Ljubljana, Slovenia. Ljubljana: [s. n.], 2020. 1 str., ilustr. [COBISS.SI-ID 1553502]
4.
SIBINOVSKA, Nadica, ŽAKELJ, Simon, ROŠKAR, Robert, KRISTAN, Katja. Suitability and
functional characterization of two Calu-3 cell models for prediction of drug permeability
across the airway epithelial barrier. International journal of pharmaceutics. [Print ed.]. 2020, vol. 585, str. 1-10. ISSN 0378-5173. DOI: 10.1016/j.ijpharm.2020.119484. [COBISS.SI-ID 18189059]
2021
5.
TRATNJEK, Larisa, SIBINOVSKA, Nadica, KRISTAN, Katja (author, corresponding author),
ERDANI-KREFT, Mateja (author, corresponding author). In vitro ciliotoxicity and cytotoxicity
testing of repeated chronic exposure to topical nasal formulations for safety studies.
Pharmaceutics. [Online ed.]. 2021, vol. 13, iss. 11, str. 1-20, ilustr. ISSN 1999-4923. https://www.mdpi.com/1999-4923/13/10/1739, Repository of the University of Ljubljana – RUL , DOI: 10.3390/pharmaceutics13111750. [COBISS.SI-ID 81714179]
project: J7-2594; funder: Slovenian Research Agency; MRIC UL
project: J7-2594; funder: Slovenian Research Agency; MRIC UL
6.
SIBINOVSKA, Nadica, BOŽIČ, Dane, BOŠKOVIĆ, Marija, KRISTAN, Katja. Prediction of pharmacokinetic
studies outcome for locally acting nasal sprays by using different in vitro methods.
International journal of pharmaceutics. [Print ed.]. 2021, vol. 601, str. 1-11, ilustr. ISSN 0378-5173. DOI: 10.1016/j.ijpharm.2021.120569. [COBISS.SI-ID 61135875]
7.
TRATNJEK, Larisa, SIBINOVSKA, Nadica, KRALJ, Slavko, MAKOVEC, Darko, KRISTAN, Katja,
ERDANI-KREFT, Mateja. Standardization of esophageal adenocarcinoma in vitro model
and its applicability for model drug testing. Scientific reports. mar. 2021, vol. 11, str. 1-23, ilustr. ISSN 2045-2322. https://www.nature.com/articles/s41598-021-85530-w.pdf, Repository of the University of Ljubljana – RUL , DOI: 10.1038/s41598-021-85530-w. [COBISS.SI-ID 56692995]
8.
SIBINOVSKA, Nadica. Suitability and reliability of in vitro epithelial cell models for nasal and pulmonary
drug permeability determination : doctoral thesis = Ustreznost in zanesljivost in
vitro epitelijskih celičnih modelov za določanje nazalne in pulmonalne permeabilnosti
zdravilnih učinkovin : doktorska disertacija. Ljubljana: [N. Sibinovska], 2021. 185 str., graf. prikazi, tabele. Repository of the University of Ljubljana – RUL , http://www.dlib.si/details/URN:NBN:SI:doc-UPSGVVJI. [COBISS.SI-ID 80440579]
2022
9.
SIBINOVSKA, Nadica, ŽAKELJ, Simon, TRONTELJ, Jurij, KRISTAN, Katja. Applicability
of RPMI 2650 and Calu-3 cell models for evaluation of nasal formulations. Pharmaceutics. [Online ed.]. 2022, vol. 14, issue 2, art.369, str. 1-19. ISSN 1999-4923. Repository of the University of Ljubljana – RUL , DOI: 10.3390/pharmaceutics14020369. [COBISS.SI-ID 107048707]
project: P1-0189; funder: ARRS
project: P1-0189; funder: ARRS